Literature DB >> 421547

The advantages of open mitral commissurotomy for mitral stenosis.

A Montoya, J Mulet, R Pifarré, J M Moran, H J Sullivan.   

Abstract

Mitral commissurotomy is the treatment of choice for mitral stenosis. If this is not feasible, replacement of the valve becomes necessary. Open commissurotomy has been performed at Loyola University Medical Center, Maywood, Ill, in 105 patients since 1970. The mean age was 45 years. The indication for surgery was heart failure in 92 of the cases. Sixty of the patients were in class 3 of the New York Heart Association (NYHA) classification. Eighty-five underwent open mitral commissurotomy alone. This was not feasible in 42 patients scheduled for it who required valvular replacement. Twenty-five patients had a left atrial thrombus. Two patients died, one from aortic dissection and the other from acute infarction in the perioperative period. Ninety-eight patients are NYHA class 1 or 2 at present. Two patients required valvular replacement following the commissurotomy. The low mobidity and mortality with excellent long-term results support our contention that open mitral commissurotomy is the treatment of choice for mitral stenosis.

Entities:  

Mesh:

Year:  1979        PMID: 421547     DOI: 10.1378/chest.75.2.131

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Preoperative clinical predictors of long term survival in mitral stenosis: analysis of 200 cases followed for up to 27 years after closed mitral valvotomy.

Authors:  P C Gautam; N Coulshed; E J Epstein; M J Llewellyn; E Vargas; R C Tallis
Journal:  Thorax       Date:  1986-05       Impact factor: 9.139

Review 2.  [Diagnosis and differential therapy of mitral stenosis].

Authors:  D Fassbender; H K Schmidt; H Seggewiss; H Mannebach; N Bogunovic
Journal:  Herz       Date:  1998-11       Impact factor: 1.443

3.  Mitral stenosis with severe pulmonary hypertension.

Authors:  S S Kabbani; T Bashour; R Dunlap; E S Hanna
Journal:  Tex Heart Inst J       Date:  1982-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.